Arbuckle Stuart A 4

4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 14, 2025

Insider Transaction Report

Form 4
Period: 2025-02-12
Arbuckle Stuart A
EVP\Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2025-02-12+7,90377,446 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    140
Footnotes (1)
  • [F1]Restricted stock unit award that vests in installments beginning on 02/24/2026.

Documents

1 file
  • 4
    wk-form4_1739567177.xmlPrimary

    FORM 4